ba0003pp248 | Osteoporosis: evaluation and imaging | ECTS2014
Mawatari Taro
, Ohishi Masanobu
, Iwamoto Yukihide
Minodronate has been reported to increase bone mineral density (BMD) and reduce fracture risk. The purpose of this study was to clarify the effect of minodronate on the three-dimensional vertebral microarchitecture in vivo.Minodronate-treated osteoporosis female patients (n=9) and non-treated age-matched historical control (n=5) were retrospectively evaluated. After areal BMD (aBMD) evaluation by DXA, 3rd lumbar spine was scann...